BD (Becton, Dickinson and Company)

Medical technology company that serves healthcare institutions, life science researchers, clinical laboratories and the industry.

Launch date

1897

Employees

Market cap

Enterprise valuation

CAD111.9b (Public information from Sep 2024)

Franklin Lakes New Jersey (HQ)

http://www.bd.com/

https://twitter.com/bdandco https://www.facebook.com/bectondickinsonandco https://www.linkedin.com/company/bd1

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	17.3b	17.1b	20.2b	18.9b	19.4b	20.1b	21.4b
% growth	8 %	(1 %)	18 %	(7 %)	3 %	4 %	6 %
EBITDA	4.1b	4.0b	5.2b	4.6b	4.7b	-	-
% EBITDA margin	24 %	23 %	26 %	24 %	24 %	-	-
Profit	1.2b	874m	2.1b	1.8b	1.5b	-	-
% profit margin	7 %	5 %	10 %	9 %	8 %	-	-
R&D budget	1.1b	1.1b	1.3b	1.3b	1.2b	-	-
R&D % of revenue	6 %	6 %	7 %	7 %	6 %	-	-

Date	Investors	Amount	Round
-	New Leaf Venture Partners Tigris Ventures	N/A	-
Jan 1984	N/A	N/A	IPO
Jan 2024*	Affinity Wealth Management	$2.2m	Post IPO Equity
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

By Country

United States 11 Israel 2 Germany 1 Sweden 1 United Kingdom 1 Switzerland 1 Spain 1

By Industry

Health 18 Robotics 2 Enterprise Software 1 Legal 1

By Round

ACQUISITION 13 GRANT 1 SERIES C 1 EARLY VC 1 SERIES A 1 SPAC PRIVATE PLACEMENT 1

GenCell Biosystems

ACQUISITION by BD (Becton, Dickinson and Company) Oct 2014

ACQUISITION by BD (Becton, Dickinson and Company) Jul 2011

Velano Vascular

ACQUISITION by BD (Becton, Dickinson and Company) Jul 2021

ACQUISITION by BD (Becton, Dickinson and Company) Oct 2014

ACQUISITION by BD (Becton, Dickinson and Company) Jun 2022

ACQUISITION by BD (Becton, Dickinson and Company) Dec 2021

ACQUISITION by BD (Becton, Dickinson and Company) Feb 2012

ACQUISITION by BD (Becton, Dickinson and Company) Feb 2022